Canopy growth corp CGC.US 總覽分析

美股醫療保健
(CGC 無簡報檔)

CGC 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分較低,若以價值投資為目標,已經有長期投資部位可能需陸續減碼

CGC 近期報酬表現

3.88%

Canopy growth corp

1.31%

同產業平均

0.58%

S&P500

與 CGC 同產業的標的表現

  • XTLB Xtl biopharmaceuticals limited
    價值 3 分趨勢 3 分波段 2 分籌碼 -股利 1 分
    查看更多

CGC 公司資訊

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

CGC 股價